PIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer

PIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer

Abstract Background Personalized and effective treatments for pancreatic ductal adenocarcinoma (PDAC) continue to remain elusive. Novel clinical trial designs that enable continual and rapid evaluation of novel therapeutics are needed. Here, we describe a platform clinical trial to address this unme...

Full description

Bibliographic Details
Main Authors: Julia E. Douglas, Suyu Liu, Junsheng Ma, Robert A. Wolff, Shubham Pant, Anirban Maitra, Eric P. Tamm, Priya Bhosale, Matthew H. G. Katz, Gauri R. Varadhachary, Eugene J. Koay
Format: Article
Language:English
Published: BMC 2022-01-01
Series:BMC Cancer
Subjects:
Pancreatic cancer
PIONEER
Phase II
Randomized platform trial
Resectable
Borderline resectable
Online Access:https://doi.org/10.1186/s12885-021-09095-7

Internet

https://doi.org/10.1186/s12885-021-09095-7

Similar Items